Papillomavirus Genomes Associate with BRD4 to Replicate at Fragile Sites in the Host Genome

PLoS Pathogens

Volumn 10, Issue 5, 2014, Pages

  Jang, Moon Kyoo ^a   Shen, Kui ^a   McBride, Alison A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRD4 PROTEIN, HUMAN; DNA BINDING PROTEIN; E1 PROTEIN, HUMAN PAPILLOMAVIRUS 16; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; NUCLEAR PROTEIN; ONCOGENE PROTEIN E2, HUMAN PAPILLOMAVIRUS TYPE 1; ONCOPROTEIN; PROTEIN BINDING; TRANSCRIPTION FACTOR;

CELL CULTURE; CHROMOSOME FRAGILE SITE; DNA REPAIR; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN GENOME; METABOLISM; PAPILLOMAVIRIDAE; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS REPLICATION;

CELLS, CULTURED; CHROMOSOME FRAGILE SITES; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENOME, HUMAN; GENOME, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN BINDING; TRANSCRIPTION FACTORS; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 84901648254     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004117     Document Type: Article

References (81)

1. Skiadopoulos MH, McBride AA, (1998) Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin. J Virol 72: 2079-2088.
2. Ilves I, Kivi S, Ustav M, (1999) Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which is mediated by the viral E2 protein and its binding sites. Journal of Virology 73: 4404-4412.
3. Lehman CW, Botchan MR, (1998) Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation. ProcNatlAcadSci USA 95: 4338-4343.
4. You J, Croyle JL, Nishimura A, Ozato K, Howley PM, (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117: 349-360.
5. Baxter MK, McPhillips MG, Ozato K, McBride AA, (2005) The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol 79: 4806-4818.
6. Wu SY, Lee AY, Hou SY, Kemper JK, Erdjument-Bromage H, et al. (2006) Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev 20: 2383-2396.
7. McPhillips MG, Ozato K, McBride AA, (2005) Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J Virol 79: 8920-8932.
8. Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, et al. (2010) Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci U S A 107: 3752-3757.
9. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA, (2006) Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol 80: 9530-9543.
10. Wang X, Helfer CM, Pancholi N, Bradner JE, You J, (2013) Recruitment of brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J Virol 87: 3871-3884.
11. Sakakibara N, Chen D, Jang MK, Kang DW, Luecke HF, et al. (2013) Brd4 Is Displaced from HPV Replication Factories as They Expand and Amplify Viral DNA. PLoS Pathog 9: e1003777.
12. Dey A, Ellenberg J, Farina A, Coleman AE, Maruyama T, et al. (2000) A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G(2)-to-M transition. Mol Cell Biol 20: 6537-6549.
13. Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K, (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A 100: 8758-8763.
14. Jang MK, Mochizuki K, Zhou MS, Jeong HS, Brady JN, et al. (2005) The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Molecular Cell 19: 523-534.
15. Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, et al. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146: 904-917.
16. Dey A, Nishiyama A, Karpova T, McNally J, Ozato K, (2009) Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell 20: 4899-4909.
17. Mochizuki K, Nishiyama A, Jang MK, Dey A, Ghosh A, et al. (2008) The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. J Biol Chem 283: 9040-9048.
18. Weidner-Glunde M, Ottinger M, Schulz TF, (2010) WHAT do viruses BET on? Front Biosci (Landmark Ed) 15: 537-549.
19. McBride AA, Jang MK, (2013) Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses 5: 1374-1394.
20. Loven J, Hoke HA, Lin CY, Lau A, Orlando DA, et al. (2013) Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 153: 320-334.
21. Belkina AC, Denis GV, (2012) BET domain co-regulators in obesity, inflammation and cancer. Nature reviews Cancer 12: 465-477.
22. zur Hausen H, Gissmann L, Steiner W, Dippold W, Dreger I, (1975) Human papilloma viruses and cancer. Bibl Haematol pp. 569-571.
23. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, et al. (2009) A review of human carcinogens-Part B: biological agents. Lancet Oncology 10: 321-322.
24. Jeon S, Allenhoffmann BL, Lambert PF, (1995) Integration of Human Papillomavirus Type-16 into the Human Genome Correlates with a Selective Growth Advantage of Cells. Journal of Virology 69: 2989-2997.
25. Thorland EC, Myers SL, Gostout BS, Smith DI, (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22: 1225-1237.
26. Popescu NC, DiPaolo JA, (1989) Preferential sites for viral integration on mammalian genome. Cancer Genet Cytogenet 42: 157-171.
27. Moody CA, Laimins LA, (2009) Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation. Plos Pathogens 5: e1000605.
28. Fradet-Turcotte A, Bergeron-Labrecque F, Moody CA, Lehoux M, Laimins LA, et al. (2011) Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol 85: 8996-9012.
29. Sakakibara N, Mitra R, McBride AA, (2011) The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol 85: 8981-8995.
30. Gillespie KA, Mehta KP, Laimins LA, Moody CA, (2012) Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol 86: 9520-9526.
31. Sakakibara N, Chen D, McBride AA, (2013) Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells. PLoS Pathog 9: e1003321.
32. Helmrich A, Ballarino M, Tora L, (2011) Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol Cell 44: 966-977.
33. McBride AA, (2013) The Papillomavirus E2 proteins. Virology 445: 57-79.
34. Jang MK, Kwon D, McBride AA, (2009) Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin. J Virol 83: 2592-2600.
35. Martinez-Balbas MA, Dey A, Rabindran SK, Ozato K, Wu C, (1995) Displacement of sequence-specific transcription factors from mitotic chromatin. Cell 83: 29-38.
36. Cardenas-Mora J, Spindler JE, Jang MK, McBride AA, (2008) Dimerization of the papillomavirus E2 protein is required for efficient mitotic chromosome association and Brd4 binding. J Virol 82: 7298-7305.
37. Schweiger MR, Ottinger M, You J, Howley PM, (2007) Brd4 independent transcriptional repression function of the papillomavirus E2 proteins. J Virol 81: 9612-9622.
38. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, et al. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468: 1119-1123.
39. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318.
40. Peng YC, Breiding DE, Sverdrup F, Richard J, Androphy EJ, (2000) AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J Virol 74: 5872-5879.
41. Crump NT, Hazzalin CA, Bowers EM, Alani RM, Cole PA, et al. (2011) Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP. Proc Natl Acad Sci U S A 108: 7814-7819.
42. Ensminger AW, Chess A, (2004) Coordinated replication timing of monoallelically expressed genes along human autosomes. Hum Mol Genet 13: 651-658.
43. Hansen RS, Canfield TK, Lamb MM, Gartler SM, Laird CD, (1993) Association of fragile X syndrome with delayed replication of the FMR1 gene. Cell 73: 1403-1409.
44. Debatisse M, Le Tallec B, Letessier A, Dutrillaux B, Brison O, (2012) Common fragile sites: mechanisms of instability revisited. Trends Genet 28: 22-32.
45. Letessier A, Millot GA, Koundrioukoff S, Lachages AM, Vogt N, et al. (2011) Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470: 120-123.
46. Le Tallec B, Dutrillaux B, Lachages AM, Millot GA, Brison O, et al. (2011) Molecular profiling of common fragile sites in human fibroblasts. Nature structural & molecular biology 18: 1421-1423.
47. Chan KL, Palmai-Pallag T, Ying S, Hickson ID, (2009) Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nature cell biology 11: 753-760.
48. Lossaint G, Larroque M, Ribeyre C, Bec N, Larroque C, et al. (2013) FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling. Mol Cell 51: 678-690.
49. Naim V, Rosselli F, (2009) The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat Cell Biol 11: 761-768.
50. Le Tallec B, Millot GA, Blin ME, Brison O, Dutrillaux B, et al. (2013) Common Fragile Site Profiling in Epithelial and Erythroid Cells Reveals that Most Recurrent Cancer Deletions Lie in Fragile Sites Hosting Large Genes. Cell Rep 4: 420-428.
51. Fungtammasan A, Walsh E, Chiaromonte F, Eckert KA, Makova KD, (2012) A genome-wide analysis of common fragile sites: what features determine chromosomal instability in the human genome? Genome research 22: 993-1005.
52. Cannizzaro LA, Durst M, Mendez MJ, Hecht BK, Hecht F, (1988) Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genet Cytogenet 33: 93-98.
53. Das P, Thomas A, Mahantshetty U, Shrivastava SK, Deodhar K, et al. (2012) HPV genotyping and site of viral integration in cervical cancers in Indian women. PLoS One 7: e41012.
54. Li H, Yang Y, Zhang R, Cai Y, Yang X, et al. (2013) Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions. J Clin Virol 56: 342-347.
55. Xu B, Chotewutmontri S, Wolf S, Klos U, Schmitz M, et al. (2013) Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas. PLoS One 8: e66693.
56. Zhao X, Liu Q, Cai Q, Li Y, Xu C, et al. (2012) Dr.VIS: a database of human disease-related viral integration sites. Nucleic Acids Res 40: D1041-1046.
57. Kraus I, Driesch C, Vinokurova S, Hovig E, Schneider A, et al. (2008) The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer research 68: 2514-2522.
58. Akagi K, Li J, Broutian TR, Padilla-Nash H, Xiao W, et al. (2013) Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability. Genome Res 24: 185-99 doi: 10.1101/gr.164806.
59. You J, Schweiger MR, Howley PM, (2005) Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J Virol 79: 14956-14961.
60. Stubenrauch F, Colbert AM, Laimins LA, (1998) Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J Virol 72: 8115-8123.
61. Senechal H, Poirier GG, Coulombe B, Laimins LA, Archambault J, (2007) Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358: 10-17.
62. Bester AC, Roniger M, Oren YS, Im MM, Sarni D, et al. (2011) Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145: 435-446.
63. Letessier A, Birnbaum D, Debatisse M, Chaffanet M, (2011) [Genome: does a paucity of initiation events lead to fragility?]. Med Sci (Paris) 27: 707-709.
64. Banerjee NS, Wang HK, Broker TR, Chow LT, (2011) Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem 286: 15473-15482.
65. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF, (2005) Human papillomavirus type 16 E1∧E4 contributes to multiple facets of the papillomavirus life cycle. J Virol 79: 13150-13165.
66. Jiang Y, Lucas I, Young DJ, Davis EM, Karrison T, et al. (2009) Common fragile sites are characterized by histone hypoacetylation. Human molecular genetics 18: 4501-4512.
67. Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, et al. (2013) Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153: 307-319.
68. Zhao R, Nakamura T, Fu Y, Lazar Z, Spector DL, (2011) Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nat Cell Biol 13: 1295-1304.
69. Floyd SR, Pacold ME, Huang Q, Clarke SM, Lam FC, et al. (2013) The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature 498: 246-250.
70. Oliveira JG, Colf LA, McBride AA, (2006) Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci U S A 103: 1047-1052.
71. Danos O, Katinka M, Yaniv M, (1980) Molecular cloning, refined physical map and heterogeneity of methylation sites of papilloma virus type 1a DNA. Eur J Biochem 109: 457-461.
72. Cole ST, Danos O, (1987) Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol 193: 599-608.
73. Goldsborough MD, DiSilvestre D, Temple GF, Lorincz AT, (1989) Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus. Virology 171: 306-311.
74. Van Doorslaer K, Tan Q, Xirasagar S, Bandaru S, Gopalan V, et al. (2013) The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res 41: D571-578.
75. Auersperg N, (1964) Long-Term Cultivation of Hypodiploid Human Tumor Cells. J Natl Cancer Inst 32: 135-163.
76. Hummel M, Hudson JB, Laimins LA, (1992) Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 66: 6070-6080.
77. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, et al. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7: 562-578.
78. Wilson R, Laimins LA, (2005) Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose. Methods Mol Med 119: 157-169.
79. Toedling J, Huber W, (2008) Analyzing ChIP-chip Data Using Bioconductor. Plos Computational Biology 4: e1000227.
80. Toedling J, Sklyar O, Huber W, (2007) Ringo-an R/Bioconductor package for analyzing ChIP-chip readouts. BMC bioinformatics 8: 221.
81. Favorov A, Mularoni L, Cope LM, Medvedeva Y, Mironov AA, et al. (2012) Exploring massive, genome scale datasets with the GenometriCorr package. PLoS computational biology 8: e1002529.